— Know what they know.
Not Investment Advice

SNSE NASDAQ

Sensei Biotherapeutics, Inc.
1W: +6.5% 1M: -30.1% 3M: -53.7% YTD: +43.5% 1Y: +106.4% 3Y: -49.5% 5Y: -94.3%
$13.85
Last traded 2026-06-15 — delisted
NASDAQ · Healthcare · Biotechnology · $18.6M mcap · 811874 float · 6.42% daily turnover · Short 40% of daily vol

Supply Chain Overview

1 relationships
1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2023-03-07
Earliest Filing
2023-03-07
Latest Filing
partner: 1

Counterparties (Filed by SNSE)

1 relationships

Companies named in SNSE's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
American Stock Transfer & Trust Company, LLC AIG partner Rights agent for the Stockholder Rights Agreement 2023-03-07 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-06-18 Material Agreement; Other Events; Exhibits Agreement View
2026-06-15 Termination of Agreement; Officer/Director Change; Bylaws Amendment; Regulation FD; Other Events; Ex View
2026-06-10 Officer/Director Change; Bylaws Amendment; Shareholder Vote; Exhibits View
2026-05-22 Other Events View
2026-05-21 Other Events; Exhibits View
2026-05-15 Earnings Release; Exhibits View
2026-04-16 Officer/Director Change View
2026-04-15 Exhibits View
2026-03-30 Earnings Release; Exhibits View
2026-02-18 Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Unregi Agreement Acquisition View
2026-02-13 Departure/Election of Directors; Appointment of Officers View
2025-12-23 Departure/Election of Directors; Appointment of Officers View
2025-11-14 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-10-30 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-10-17 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-08-05 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-07-09 Notice of Delisting or Transfer View
2025-06-13 Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits View
2025-05-23 Submission of Matters to a Vote of Security Holders View
2025-05-06 Results of Operations and Financial Condition; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms